ClinicalTrials.gov record
Terminated Not applicable Interventional Results available

Efficacy and Safety Study of NeuroStar TMS Therapy in Patients With Major Depressive Disorder With Postpartum Onset

ClinicalTrials.gov ID: NCT01842542

Public ClinicalTrials.gov record NCT01842542. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 5:58 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Study to Evaluate the Efficacy and Safety of the Neuronetics NeuroStar TMS Therapy System in Patients With Major Depressive Disorder (MDD) With Postpartum Onset.

Study identification

NCT ID
NCT01842542
Recruitment status
Terminated
Study type
Interventional
Phase
Not applicable
Lead sponsor
Neuronetics
Other
Enrollment
25 participants

Conditions and interventions

Interventions

  • NeuroStar Transcranial Magnetic Stimulation (TMS) Device

Device

Eligibility (public fields only)

Age range
18 Years to 50 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2013
Primary completion
Jun 30, 2015
Completion
Jul 31, 2015
Last update posted
Feb 9, 2025

2013 – 2015

United States locations

U.S. sites
8
U.S. states
7
U.S. cities
8
Facility City State ZIP Site status
Hartford Hospital Institute of Living Hartford Connecticut 06102
UF Health Adult Psychiatry - Springhill Gainesville Florida 32606
Harmonex Neuroscience and Research of Pensacola Pensacola Florida 32502
Rush University Medical Center Chicago Illinois 60612
Integrative Psychiatry Louisville Kentucky 40222
TMS Medical Associates of NY New York New York 10022
TMS Center of Lehigh Valley Allentown Pennsylvania 18104
University of Utah - Neuropsychiatric Institute Salt Lake City Utah 84108

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01842542, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 9, 2025 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01842542 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →